CGC - Canopy Growth Corporation

NYSE - NYSE Delayed Price. Currency in USD
32.05
+1.22 (+3.96%)
At close: 4:03PM EDT

33.78 +1.77 (5.53%)
Pre-Market: 9:09AM EDT

Stock chart is not supported by your current browser
Previous Close30.83
Open30.40
Bid33.52 x 1100
Ask33.65 x 800
Day's Range30.30 - 32.88
52 Week Range16.74 - 32.88
Volume4,519,031
Avg. Volume1,357,832
Market Cap6.547B
Beta3.12
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group15 minutes ago

    Canopy Growth Corporation Completes C$500 Million Convertible Senior Notes Offering

    SMITHS FALLS, ON, June 20, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") announced today the closing of its previously announced offering of C$500 million aggregate principal amount of its 4.25% convertible senior notes due 2023 (the "notes"). The initial conversion rate for the notes is 20.7577 common shares ("common shares") per C$1,000 principal amount of the notes, equivalent to an initial conversion price of approximately C$48.18 per share. The Company intends to use the net proceeds from the sale of the notes for supporting expansion initiatives and general corporate purposes, including working capital requirements.

  • ACCESSWIRE1 hour ago

    Today's Research Reports on Stocks to Watch: Canopy Growth and GW Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / June 20, 2018 / As Canada officially legalized recreational marijuana this week, shares of Canopy Growth skyrocketed after announcing a multi-year agreement with Neptune Technologies & Bioressources Inc. Shares of GW Pharmaceuticals were modestly in the red despite any news. Canopy Growth Corporation shares closed up almost 4% on Tuesday with nearly 4.5 million shares traded. The stock hit a brand new high of $32.88 yesterday after it was revealed that Neptune Technologies & Bioressources Inc. has entered into a multi-year agreement with Canopy Growth to supplement Canopy Growth's extraction, refinement, and extract product formulation capacity.

  • Market Exclusive2 hours ago

    Market Morning: Chinese US Investment Collapses, Canadian Cannabis, GE Gets DOWnsized

    China’s Nuclear Option: Stop Buying US Treasuries Bloomberg is floating the idea this morning that all China must needs to win the burgeoning trade war with the US is stop loaning the US money. This is called the “nuclear option” apparently, though it literally requires no action at all. Bloomberg also has its eyes on […] The post Market Morning: Chinese US Investment Collapses, Canadian Cannabis, GE Gets DOWnsized appeared first on Market Exclusive.

  • CNW Groupyesterday

    Neptune Announces Multi-year Agreement with Canopy Growth to Provide Extracted Cannabis Products

    LAVAL, QC, June 19, 2018 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT - News) (TSX:NEPT.TO - News), today announced that it entered into a multi-year agreement with Canopy Growth (TSX:WEED.TO - News) (NYSE:CGC - News). Under the terms of the agreement, Neptune will supplement Canopy Growth's extraction, refinement, and extract product formulation capacity. "We are truly excited to partner with such a great company as Canopy Growth.

  • ACCESSWIRE2 days ago

    Today's Research Reports on Trending Tickers: Canopy Growth and AbbVie

    NEW YORK, NY / ACCESSWIRE / June 18, 2018 / U.S. market plunged on Friday, but well-off session lows as investors appeared to look at previous signs of escalating trade tension between Washington and Beijing. ...

  • The Simplicity of the SpectrumTM Meets the Sophistication of Softgels
    CNW Group2 days ago

    The Simplicity of the SpectrumTM Meets the Sophistication of Softgels

    SMITHS FALLS, ON, June 18, 2018 /CNW/ - Spectrum Cannabis ("Spectrum Cannabis"), the global medical subsidiary of Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED.TO - News) (NYSE:CGC - News) is proud to announce the introduction of convenient, colour-coded Softgels to its product line in Canada.

  • CNW Group5 days ago

    Canopy Growth Corporation Upsizes and Prices Offering of Convertible Senior Notes

    SMITHS FALLS, ON, June 15, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") announced today that it has priced its previously announced offering of convertible senior notes due 2023 (the "notes"). The Company will issue C$500 million aggregate principal amount of the notes. Canopy Growth has granted the initial purchasers of the notes an option to purchase up to an additional C$100 million aggregate principal amount of notes.

  • GlobeNewswire5 days ago

    Analysis: Positioning to Benefit within Canopy Growth, Aurora Cannabis, CannTrust, AbbVie, Cronos Group, and Scotts Miracle-Gro — Research Highlights Growth, Revenue, and Consolidated Results

    NEW YORK, June 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy ...

  • Is Aurora Cannabis Inc. (TSX:ACB) Pulling a Valeant Pharmaceuticals Intl Inc. (TSX:VRX)?
    The Motley Fool6 days ago

    Is Aurora Cannabis Inc. (TSX:ACB) Pulling a Valeant Pharmaceuticals Intl Inc. (TSX:VRX)?

    Aurora Cannabis Inc. (TSX:ACB) is at it again with the acquisitions. Here's what investors need to know.

  • Aurora Cannabis Is Going Head to Head With Canopy Growth Over This High-Margin Product
    Motley Fool6 days ago

    Aurora Cannabis Is Going Head to Head With Canopy Growth Over This High-Margin Product

    Is this medical cannabis product big enough for two major marijuana players?

  • Canopy Growth Expects Strong Q4 Earnings Growth
    Market Realist6 days ago

    Canopy Growth Expects Strong Q4 Earnings Growth

    Yesterday, Canopy Growth (CGC) (WEED) announced that it plans to release its earnings on June 27 for its fiscal fourth quarter and fiscal year, which ended on March 31. In its press release, Canopy Growth also offered a preview of what to expect from its results. The company stated that it expects revenues to be between 22.5 million and 23 million Canadian dollars for the quarter compared to 14.7 million Canadian dollars a year ago, an increase of 53% to 56%.

  • Market Exclusive6 days ago

    Market Morning: Bitcoin Untethered, Fed Talks Marijuana, Whole Amazon Foods Clash

    Bitcoin Untethered, Literally Speculation is mounting that the price of bitcoin (BTC-USD) and other altcoins like ethereum (ETH-USD) and bitcoin cash (BCH-USD) has been manipulated using a scheme pretty much identical to what the Federal Reserve uses to inflate the price of US treasuries. Tether (USDT-USD), a crytpocurrency token supposedly backed by, or “tethered” to […] The post Market Morning: Bitcoin Untethered, Fed Talks Marijuana, Whole Amazon Foods Clash appeared first on Market Exclusive.

  • CNW Group7 days ago

    Canopy Growth Corporation to Announce Fourth Quarter and Fiscal Year 2018 Financial Results

    SMITHS FALLS, ON, June 13, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") will release its financial results for the fourth quarter and fiscal year ended March 31, 2018 on June 27, 2018. Following the release of its fourth quarter and fiscal year 2018 financial results, Canopy Growth will host a conference call and audio webcast with Bruce Linton, Chairman and Chief Executive Officer, and Tim Saunders, Executive Vice-President and Chief Financial Officer, at 8:30 am Eastern Time the same day. The Company also announced that, based upon information currently available to management, it anticipates reporting revenue of between $22.5 million and $23 million for the quarter ended March 31, 2018, compared to approximately $14.7 million for the quarter ended March 31, 2017.

  • CNW Group7 days ago

    Canopy Growth Corporation Announces Offering of C$400.0 Million of Convertible Senior Notes Due 2023

    SMITHS FALLS, ON, June 13, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) ("Canopy Growth" or the "Company") announced today that it proposes to offer C$400.0 million aggregate principal amount of convertible senior notes due 2023 (the "notes"), subject to market conditions and other factors. The notes will be sold to accredited investors in Canada pursuant to an exemption from the prospectus requirements of Canadian securities laws.  Canopy Growth also intends to grant to the initial purchasers of the notes an option to purchase up to an additional C$60.0 million aggregate principal amount of notes. Canopy Growth has been advised by Greenstar Canada Investment Limited Partnership, an affiliate of Constellation Brands, Inc., that it intends to participate in the offering.

  • 3 Reasons Marijuana Legislation in the U.S. Could Be Coming Soon
    The Motley Fool7 days ago

    3 Reasons Marijuana Legislation in the U.S. Could Be Coming Soon

    Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and other pot stocks could see tremendous growth opportunities once the U.S. legalizes pot.

  • ACCESSWIRE7 days ago

    Canopy Growth, First of Its Kind NYSE Stock, Gains as Canadian Senate Says Yes to Cannabis

    NEW YORK, NY / ACCESSWIRE / June 13, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Canopy Growth Corp (CGC), a licensed cannabis producer. CGC already has commercial operations up and running, with well-diversified operations in eight countries, including Canada and having a licensed domestic growing platform of 2.4 million sq. ft. CGC recently announced its listing on the New York Stock Exchange and has become the first publicly traded federally regulated cannabis company in North America, and the first to be included in the S&P/TSX Composite index.

  • Canada's Historic Marijuana Vote: The Good and the Bad
    Motley Fool8 days ago

    Canada's Historic Marijuana Vote: The Good and the Bad

    Despite making history, there are still a lot of unknowns to be hashed out in the weeks to come.

  • The Motley Fool8 days ago

    3 Explosive Growth Stocks That Are Just Getting Started!

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) are just two of three explosive stocks that could give your portfolio the market-beating edge it needs over the next year.

  • Medical Cannabis Leadership from Canopy Growth and Subsidiary Spectrum Cannabis
    CNW Group8 days ago

    Medical Cannabis Leadership from Canopy Growth and Subsidiary Spectrum Cannabis

    SMITHS FALLS, ON, June 12, 2018 /CNW/ - Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News) (the "Company" or "Canopy Growth") is pleased to provide the following updates on its medical cannabis program and to re-affirm its strong commitment to medical cannabis, the patients who depend on it, and the Healthcare Professionals who prescribe it. Marking a major milestone for medical cannabis in Canada, a Phase IIb "in-human" clinical trial application was submitted by Canopy Health Innovations Inc. to evaluate the use of medical cannabis in the treatment of insomnia.

  • CNW Group9 days ago

    Canopy Growth provides operational update regarding licensing arrangement with Bedrocan International

    SMITHS FALLS, ON, June 11, 2018 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED.TO - News) (NYSE:CGC - News) and its subsidiary, Bedrocan Canada Inc. ("BC") are pleased to announce that they have reached an agreement (the "Agreement") with Bedrocan International BV ("BI") (together, the "Parties") to bring the Parties' licensing arrangement to a close. Canopy Growth will retain the licensed production facility, licensed sales facility, and all associated licenses owned and operated by BC. Management will redeploy these facilities, free of the current royalty structure and fixed production practices, to develop new premium branded cannabis offerings.

  • Baystreet9 days ago

    Stocks in play: The Green Organic Dutchman Holdings Ltd.

    Announced that, effective June 8th, its wholly-owned subsidiary, Medican Organic Inc. has received its ...

  • Cannabis Stocks Rose Last Week on Approval of Cannabis Act
    Market Realist9 days ago

    Cannabis Stocks Rose Last Week on Approval of Cannabis Act

    Last week was one of the most important weeks for the cannabis sector, as Canada’s Senate approved Bill C-45, which is also known as the “Cannabis Act.” The approval of this bill was the most critical hurdle to overcome for the cannabis sector. Read more at Canada’s Senate Approves Cannabis Act: Positive for Investors. Most of the sector ETFs were broadly positive last week.

  • 3 Biggest Winners From Canada's Recreational Marijuana Milestone
    Motley Fool10 days ago

    3 Biggest Winners From Canada's Recreational Marijuana Milestone

    Don't worry that most marijuana stocks fell after the big Canadian Senate vote on Thursday. These three stocks should be winners over the long run.

  • 3 Growth Stocks to Pick Up in June
    The Motley Fool10 days ago

    3 Growth Stocks to Pick Up in June

    Trade tensions loom large at the weekend G7 meetings, but investors should not turn their backs on stocks like Dollarama Inc. (TSX:DOL) just yet.

  • The Potential in Europe’s Cannabis Market Should Motivate You to Buy These 2 Cannabis Stocks
    The Motley Fool11 days ago

    The Potential in Europe’s Cannabis Market Should Motivate You to Buy These 2 Cannabis Stocks

    The growth of the European market should signal investors to stick with stocks like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) long term.